Ronapreve for prophylaxis and treatment of covid-19

Off BMJ, British Medical Journal, COVID-19, Science and Health, Science and Research, Uncategorized

On 20 August 2021, Ronapreve received conditional marketing authorisation for the prevention and treatment of covid-19 in the UK.1 Ronapreve (REGEN-COV in the US) comprises two monoclonal antibodies,…


Read Original Article: Ronapreve for prophylaxis and treatment of covid-19 »

About The Author